|
|||||
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter |
Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
BCRX | Babu Yarlagadda S | Chief Discovery Officer | Nov 14 | Option Exercise | 1.42 | 100,000 | 142,000 | 330,056 | Nov 16 04:19 PM |
BCRX | Babu Yarlagadda S | Chief Discovery Officer | Nov 14 | Sale | 13.88 | 31,515 | 437,428 | 298,541 | Nov 16 04:19 PM |
BCRX | Babu Yarlagadda S | Chief Discovery Officer | Mar 07 | Sale | 17.16 | 20,000 | 343,200 | 230,056 | Mar 09 04:24 PM |
BCRX | Babu Yarlagadda S | Chief Discovery Officer | Dec 07 | Option Exercise | 4.73 | 62,000 | 293,260 | 245,156 | Dec 09 04:38 PM |
BCRX | Babu Yarlagadda S | Chief Discovery Officer | Dec 07 | Sale | 12.20 | 30,100 | 367,220 | 215,056 | Dec 09 04:38 PM |
BCRX | Babu Yarlagadda S | Senior VP - Drug Discovery | Feb 19 | Option Exercise | 4.15 | 50,000 | 207,500 | 205,587 | Feb 23 04:25 PM |
BCRX | Babu Yarlagadda S | Senior VP - Drug Discovery | Nov 18 | Buy | 1.45 | 25,000 | 36,250 | 155,587 | Nov 18 04:03 PM |
BCRX | Babu Yarlagadda S | Senior VP - Drug Discovery | Mar 06 | Option Exercise | 3.26 | 30,000 | 97,800 | 120,618 | Mar 08 03:48 PM |
BCRX | Babu Yarlagadda S | Senior VP - Drug Discovery | Aug 25 | Sale | 4.06 | 30,000 | 121,800 | 111,428 | Aug 29 10:46 AM |
BCRX | Babu Yarlagadda S | Senior VP - Drug Discovery | Mar 19 | Sale | 10.16 | 12,105 | 122,987 | 148,697 | Mar 20 04:30 PM |
BCRX | Babu Yarlagadda S | Senior VP - Drug Discovery | Mar 05 | Sale | 10.59 | 37,400 | 396,066 | 160,802 | Mar 06 02:14 PM |
BCRX | Babu Yarlagadda S | Senior VP - Drug Discovery | Mar 04 | Sale | 10.50 | 10,495 | 110,198 | 198,202 | Mar 05 02:58 PM |
BCRX | Babu Yarlagadda S | Senior VP - Drug Discovery | Feb 24 | Option Exercise | 4.30 | 23,179 | 99,670 | 229,809 | Feb 25 02:34 PM |
BCRX | Babu Yarlagadda S | VP Drug Discovery | Mar 02 | Sale | 4.78 | 837 | 4,001 | 125,769 | Mar 05 02:30 PM |
BCRX | Babu Yarlagadda S | VP Drug Discovery | Feb 29 | Option Exercise | 0.00 | 53,668 | 0 | 106,406 | Mar 01 02:59 PM |
BCRX | Babu Yarlagadda S | VP Drug Discovery | Feb 22 | Option Exercise | 1.19 | 30,912 | 36,781 | 83,650 | Feb 23 04:40 PM |
BCRX | Babu Yarlagadda S | VP Drug Discovery | Feb 22 | Sale | 4.22 | 30,912 | 130,449 | 52,738 | Feb 23 04:40 PM |
BCRX | Babu Yarlagadda S | VP Drug Discovery | Oct 26 | Sale | 10.85 | 6,400 | 69,422 | 39,362 | Oct 28 10:14 AM |
BCRX | Babu Yarlagadda S | VP Drug Discovery | Oct 21 | Sale | 10.00 | 200 | 2,000 | 45,762 | Oct 22 01:29 PM |
BCRX | Babu Yarlagadda S | VP Drug Discovery | Oct 20 | Sale | 10.00 | 3,400 | 34,000 | 45,962 | Oct 21 04:40 PM |
BCRX | Babu Yarlagadda S | VP Drug Discovery | Sep 23 | Sale | 9.14 | 20,000 | 182,720 | 49,362 | Sep 24 03:23 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite